Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Hydroxyurea on the Prevention of Primary Stroke in Children With Sickle Cell Anemia and Elevated Transcranial Doppler (TCD) Flow Velocity

NCT00402480 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00402480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Hydroxyurea on the Prevention of Primary Stroke in Children With Sickle Cell Anemia and Elevated Transcranial Doppler (TCD) Flow Velocity
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2006
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke